Nefazodone treatment for chronic posttraumatic stress disorder: An open trial

Journal of Clinical Psychopharmacology

Volumn 20, Issue 2, 2000, Pages 159-164

  Davis, Lori L ^a,d   Nugent, Alexandria L ^b   Murray, Jenny ^a,c   Kramer, Gerald L ^b   Petty, Frederick ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEFAZODONE;

ADULT; AFFECTIVE NEUROSIS; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHRONIC DISEASE; COMBAT DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; TRIAZOLES; VETERANS;

EID: 0034091189     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200004000-00007     Document Type: Article

References (16)

1. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 1995;52:1048-60.
2. Kulka RL, Schlenger WE, Fairbank JA, Hough RL, Jordan BK, Marmar CR, Weiss DS. The National Vietnam Veterans Readjustment Study: tables of findings and technical appendices. New York: Brunner/Mazel Publishers, 1990.
3. Lambert MT, Hendrickse W, Andrews R, Zelanko J, Fowler DR. Malignant post-Vietnam stress syndrome revisited. J Nerv Ment Dis 1996;184:354-7.
4. Friedman MF, Southwick SM. Towards pharmacotherapy for posttraumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. Philadelphia: Lippincott-Raven, 1995:465-81.
5. Davis LL, Suris A, Lambert MT, Heimberg C, Petty F. Posttraumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci 1997;22:318-26.
6. Marshall RD, Schneier FR, Fallon BA, Knight CBG, Abbate LA, Goetz D, Campeas R, Liebowitz R. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol 1998;18:10-8.
7. Hemrickluecke SK, Snoddy HD, Fuller RW. Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo. Life Sci 1994;55:479-83.
8. Keller MB, Klein DN, Hirschfeld RMA, Kocsis JH, McCullough JP, Miller I, First MB, Holzer CP, Keitner GI, Marin DB. Results of the DSM-IV mood disorders field trial. Am J Psychiatry 1995;152:843-9.
9. Tollefson GD. Selective serotonin reuptake inhibitors. In: Schatzberg AF, Nemeroff CB, eds. Textbook of psychopharmacology. Washington, DC: American Psychiatric Press, 1995:161-82.
10. Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JRT. Open trial of nefazodone for combat-related posttraumatic stress disorder. J Clin Psychiatry 1998;59:9:460-4.
11. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatrie Press, 1990.
12. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a clinician-administered PTSD scale. J Trauma Stress 1995;8:75-90.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
14. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
15. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:12:517-22.
16. Rush AJ. Mood disorders in DSM-IV. In: Dunner DL, ed. Current psychiatric therapy. Philadelphia WB Saunders, 1993: 189-95.